How much is Nocion Therapeutics worth in 2026?

Nocion Therapeutics has a current valuation of N/A based on their Early Stage VC (Series A2) round and secondary market data.

How much funding has Nocion Therapeutics raised?

Nocion Therapeutics has raised N/A in total funding across 1 funding rounds.

Nocion Therapeutics

Drug Discovery

Nocion Therapeutics valuation and funding history | Last updated: August 30, 2021 | 1 funding rounds

Current Valuation

N/A

As of August 30, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A2)

$7.0M

Last Funding

Aug 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 30, 2021	Early Stage VC (Series A2)	$7.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Nocion Therapeutics is currently valued at N/A as of August 30, 2021.

Track Nocion Therapeutics Valuation Updates

Get notified when Nocion Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Nocion Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Nocion Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Nocion Therapeutics Worth in 2026?

Nocion Therapeutics is a leading private company in the Drug Discovery sector. Track Nocion Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Nocion Therapeutics Valuation is Determined

Private company valuations like Nocion Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.